Previous product
Back to products
Perjeta (Pertuzumab)
CHF3,036.09
Next product
Zejula (niraparib)
CHF5,986.42
Rubraca (rucaparib)
CHF1,908.74
Rubraca (rucaparib) is a medication used for the treatment of ovarian, fallopian tube and primary peritoneal cancer.
Category: Oncology
Reviews
There are no reviews yet.